BDBM524610 4-(6-(4-((6- methoxypyridin-3- yl)methyl)piperazin- 1-yl)pyridin-3-yl)-6- (1-(2- morpholinoethyl)- 1H-pyrazol-4- yl)pyrazolo[1,5- a]pyrazine-3- carbonitrile::US11168090, Example 52::US11851434, Example 52
SMILES COc1ccc(CN2CCN(CC2)c2ccc(cn2)-c2nc(cn3ncc(C#N)c23)-c2cnn(CCN3CCOCC3)c2)cn1
InChI Key InChIKey=HQAZOPYPNZHDSJ-UHFFFAOYSA-N
Data 4 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 4 hits for monomerid = 524610
Affinity DataIC50: 8.90nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
Affinity DataIC50: 29.6nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
Affinity DataIC50: 8.90nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114,V804M](Human)
Array Biopharma
US Patent
Array Biopharma
US Patent